Opioid antagonists

Last updated: September 09, 2025

Opioid antagonists

MSKD

MSKD

Bones of the vertebral column
Vessels and nerves of the vertebral column
Joints of the vertebral column
Muscles of the back
Anatomy of the vertebral canal
Anatomy clinical correlates: Vertebral canal
Anatomy clinical correlates: Spinal cord pathways
Anatomy clinical correlates: Bones, joints and muscles of the back
Anatomy of the suboccipital region
Ectoderm
Endoderm
Mesoderm
Development of the axial skeleton
Development of the nervous system
Central nervous system histology
Peripheral nervous system histology
Glucocorticoids
Opioid agonists, mixed agonist-antagonists and partial agonists
Non-steroidal anti-inflammatory drugs
Opioid antagonists
Carpal tunnel syndrome
Opioid use disorder
Spinal disc herniation
Degenerative disc disease
Back pain: Pathology review
Lower back pain: Clinical
Sympathetic nervous system
Parasympathetic nervous system
Introduction to the skeletal system
Introduction to the muscular system
Anatomical terminology
Anatomy of the pelvic girdle
Arteries and veins of the pelvis
Nerves and lymphatics of the pelvis
Bones of the lower limb
Fascia, vessels and nerves of the lower limb
Anatomy of the anterior and medial thigh
Muscles of the gluteal region and posterior thigh
Vessels and nerves of the gluteal region and posterior thigh
Anatomy of the popliteal fossa
Anatomy of the leg
Anatomy of the foot
Anatomy of the hip joint
Anatomy of the knee joint
Anatomy of the tibiofibular joints
Joints of the ankle and foot
Glycolysis
Glycogen metabolism
Gluconeogenesis
Glucose-6-phosphate dehydrogenase (G6PD) deficiency
Glycogen storage disease type I
Glycogen storage disease type III
Glycogen storage disease type V
Glycogen storage disease type IV
Glycogen storage disease type II (NORD)
Glycogen storage disorders: Pathology review
Cytoskeleton and intracellular motility
Osteogenesis imperfecta
Marfan syndrome
Ehlers-Danlos syndrome
Development of the limbs
Development of the muscular system
Achondroplasia
Myotonic dystrophy
Muscular dystrophy
Mitochondrial myopathy
Muscular dystrophies and mitochondrial myopathies: Pathology review
Bone histology
Skeletal muscle histology
Cartilage histology
Winged scapula
Klumpke paralysis
Erb-Duchenne palsy
Unhappy triad
Anterior cruciate ligament injury
Meniscus tear
Sprained ankle
Achilles tendon rupture
Spondylolysis
Spondylolisthesis
Pectus excavatum
Osteoporosis
Osteopetrosis
Osteomalacia and rickets
Lordosis, kyphosis, and scoliosis
Paget disease of bone
Osteoarthritis
Bursitis
Myasthenia gravis
Lambert-Eaton myasthenic syndrome
Bone disorders: Pathology review
Spina bifida
Osteoporosis medications
Skeletal system anatomy and physiology
Cartilage structure and growth
Bone remodeling and repair
Fibrous, cartilage, and synovial joints
Muscular system anatomy and physiology
Brachial plexus
Neuromuscular junction and motor unit
Sliding filament model of muscle contraction
Slow twitch and fast twitch muscle fibers
Muscle contraction
Muscle spindles and golgi tendon organs
Neuron action potential
Bones of the upper limb
Fascia, vessels and nerves of the upper limb
Anatomy of the brachial plexus
Anatomy of the pectoral and scapular regions
Anatomy of the arm
Muscles of the forearm
Vessels and nerves of the forearm
Muscles of the hand
Anatomy of the sternoclavicular and acromioclavicular joints
Anatomy of the glenohumeral joint
Anatomy of the elbow joint
Anatomy of the radioulnar joints
Joints of the wrist and hand
Anatomy of the axilla
Anatomy clinical correlates: Clavicle and shoulder
Anatomy clinical correlates: Axilla
Anatomy clinical correlates: Arm, elbow and forearm
Anatomy clinical correlates: Wrist and hand
Anatomy clinical correlates: Median, ulnar and radial nerves
Vitamin C deficiency
Nucleotide metabolism
Lesch-Nyhan syndrome
Adenosine deaminase deficiency
Orotic aciduria
Purine and pyrimidine synthesis and metabolism disorders: Pathology review
Staphylococcus epidermidis
Staphylococcus aureus
Streptococcus pyogenes (Group A Strep)
Streptococcus agalactiae (Group B Strep)
Streptococcus pneumoniae
Clostridium perfringens
Pseudomonas aeruginosa
Bacteroides fragilis
Neisseria gonorrhoeae
Mycobacterium tuberculosis (Tuberculosis)
Chlamydia trachomatis
Borrelia burgdorferi (Lyme disease)
Histoplasmosis
Candida
Miscellaneous cell wall synthesis inhibitors
Cell wall synthesis inhibitors: Penicillins
Cell wall synthesis inhibitors: Cephalosporins
Osgood-Schlatter disease (traction apophysitis)
Rotator cuff tear
Dislocated shoulder
Radial head subluxation (Nursemaid elbow)
Thoracic outlet syndrome
Ulnar claw
Iliotibial band syndrome
Patellar tendon rupture
Patellofemoral pain syndrome
Sciatica
Compartment syndrome
Rhabdomyolysis
Cleidocranial dysplasia
Osteomyelitis
Bone tumors
Chondrosarcoma
Osteochondroma
Spondylosis
Spinal stenosis
Rheumatoid arthritis
Juvenile idiopathic arthritis
Gout
Calcium pyrophosphate deposition disease (pseudogout)
Psoriatic arthritis
Ankylosing spondylitis
Reactive arthritis
Spondylitis
Septic arthritis
Baker cyst
Polymyositis
Dermatomyositis
Inclusion body myopathy
Polymyalgia rheumatica
Fibromyalgia
Rhabdomyosarcoma
Sjogren syndrome
Raynaud phenomenon
Mixed connective tissue disease
Scleroderma
Systemic lupus erythematosus
Rheumatoid arthritis and osteoarthritis: Pathology review
Gout and pseudogout: Pathology review
Scleroderma: Pathology review
Sjogren syndrome: Pathology review
Systemic lupus erythematosus (SLE): Pathology review
Seronegative and septic arthritis: Pathology review
Myalgias and myositis: Pathology review
Neuromuscular junction disorders: Pathology review
Bone tumors: Pathology review
Benign hyperpigmented skin lesions: Clinical
Seborrhoeic dermatitis
Atopic dermatitis
Contact dermatitis
Blistering skin disorders: Clinical
Skin cancer: Clinical
Papulosquamous skin disorders: Clinical
Alopecia: Clinical
Hypopigmentation skin disorders: Clinical
Hair, skin and nails
Pediatric infectious rashes: Clinical
Eczematous rashes: Clinical
Skin cancer

Transcript

Watch video only

Opioid antagonists, like the name suggests, are medications that block opioid receptors. They’re used mainly to urgently reverse the side effects of opioid agonists and to help individuals who are recovering from opioid use disorder.

Now, opioids work by binding to opioid receptors in the brain, spinal cord, and gastrointestinal tract. Some are endogenous, meaning they are produced naturally by the body, like endorphins, named for “endogenous morphine” due to their similar effects in the body. But others are exogenous, meaning they come from outside the body, like heroin and morphine, which come from the opium poppy; a flowering plant that oozes a milky white liquid.

To understand how opioids work, let’s zoom in on a region of the spinal cord that has opioid receptors. Normally, in the absence of endorphins, nociceptive fibers carry pain signals from the body to the dorsal, or posterior, horn of the spinal cord, where they release neurotransmitters like glutamate, substance P and calcitonin gene-related peptide. These neurotransmitters cause pain signals to be transmitted to the brain via ascending pain pathways.

Now, let’s say someone goes to play a rigorous game of badminton. Exercise releases endorphins which activate the three major opioid receptors located on neurons, called the mu, kappa, and delta receptors. As endorphins or other opioids bind to these receptors on the presynaptic terminals of nociceptive fibers, they inhibit the opening of calcium channels, preventing calcium influx, and thereby blocking the release of pain-causing neurotransmitters like glutamate, substance P and calcitonin gene-related peptide. At the same time, endorphins also bind to postsynaptic neurons, opening potassium channels here, leading to hyperpolarization and decreased excitability of the neuron. These effects together reduce the transmission of pain signals to the brain.

Now, opioids also have action on the body’s dopaminergic, noradrenergic, and serotonergic pathways.

In the brain’s reward pathway, located in the midbrain, opioids bind to receptors on inhibitory GABAergic neurons, causing a decrease in the release of gamma-aminobutyric acid, also known as GABA. This, in turn, leads to less inhibition of dopaminergic neurons and therefore more dopamine. This increase in dopamine is why opioids cause feelings of pleasure or euphoria.

For the noradrenergic effects, opioids inhibit noradrenergic neurons in the brain, especially in the locus coeruleus, leading to a decrease in norepinephrine release. This contributes to the sedative effects of opioids.

Last, certain opioids activate neurons that release serotonin in the spinal cord, helping to reduce pain transmission.

Now that we’ve covered how opioids work, let's talk more about some of the unwanted effects. There are opioid receptors throughout our body, like in the gastrointestinal tract. So, when a person receives a dose of morphine, it could also result in a series of unwanted side effects, like nausea, vomiting, and constipation.

Other side effects of opioids include pupillary constriction as well as flushing.

However, the most dangerous side effect is respiratory depression, caused by decreased activity in the medulla; the part of the brain that regulates breathing. This happens when a person overdoses on an opioid, like morphine, fentanyl, or heroin.

Respiratory depression can be life-threatening and should be treated right away - because the person can literally stop breathing.

Also, watch out for central nervous system depression, which can lead to coma, and cardiac problems like bradycardia and other arrhythmias.

Now in order to treat opioid overdoses, we can use an opioid antagonist like naloxone. Naltrexone on the other hand, is a medication that is helpful as maintenance therapy in opioid use disorder and alcohol use disorder. Other opioid antagonists like methylnaltrexone and alvimopan can help counteract opioid-induced constipation. These medications all bind strongly to opioid receptors without activating them.

Since naloxone has a higher affinity for opioid receptors than opioid agonists like morphine, fentanyl and heroin do, it actually displaces the agonist from the receptor and doesn’t allow another to bind. Naloxone readily crosses the blood-brain barrier and has a rapid onset and short duration of action of 1 to 2 hours.

So, when it’s given intravenously or intranasally, it can reverse the central effects of opioids within minutes, potentially saving a person’s life.

Another potential use of naloxone, is to detect when a person is physically dependent on opioids. Although not commonly done, this can sometimes be useful before starting a long-acting medication like naltrexone to help manage opioid use disorder.

Key Takeaways

Opioid antagonists are drugs that strongly bind to opioid receptors and prevent their activation. They are used to treat opioid overdose and addiction, and can also help to reverse respiratory depression and other adverse effects of opioids. Examples include drugs like naloxone, naltrexone, methylnaltrexone, and alvimopan.

Sources

  1. "Katzung & Trevor's Pharmacology Examination and Board Review,12th Edition" McGraw-Hill Education / Medical (2018)
  2. "Rang and Dale's Pharmacology" Elsevier (2019)
  3. "Goodman and Gilman's The Pharmacological Basis of Therapeutics, 13th Edition" McGraw-Hill Education / Medical (2017)
  4. "Naloxone treatment in opioid addiction: the risks and benefits" Expert Opin Drug Saf (2007)
  5. "Methylnaltrexone" Drugs (2010)
  6. "Naltrexone: A Pan-Addiction Treatment?" CNS Drugs (2016)
  7. "Approach to buprenorphine use for opioid withdrawal treatment in the emergency setting" The American Journal of Emergency Medicine (2019)